<DOC>
	<DOC>NCT01896635</DOC>
	<brief_summary>The purpose of this study is to determine whether fecal microbiota transplantation (FMT) is safe and efficacious in the treatment of chronic active ulcerative colitis (UC) by conducting a randomised controlled trial</brief_summary>
	<brief_title>Faecal Microbiota Transplantation in Ulcerative Colitis</brief_title>
	<detailed_description>This study involves the assessment of the safety and efficacy of FMT in the treatment and induction of remission for patients with mild to moderate ulcerative colitis. It is a double blind study with patients randomised in a 1:1 manner to either active or placebo therapy</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis, Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<criteria>Ulcerative colitis &gt;3 months duration Active mildmoderate ulcerative colitis (Mayo 410) Ulcerative colitis of any extent except isolated proctitis &lt; 5cm Live within driving distance of clinical site (to attend multiple study visits) Pregnancy Active gastrointestinal infection Other gastrointestinal disease / comorbidities Prior colonic surgery Recent antibiotic or probiotic use Prednisone &gt; 20mg Monoclonal antibody immunosuppressive therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Ulcerative Colitis</keyword>
	<keyword>Inflammatory Bowel Disease</keyword>
	<keyword>Fecal Transplantation</keyword>
	<keyword>Fecal Microbiota Transplantation</keyword>
</DOC>